Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder

Abstract

Objective: The purpose of this study was to examine caregiver satisfaction with the research experience in a randomized clinical trial of atomoxetine (ATX) and parent training (PT) for attention-deficit/hyperactivity disorder (ADHD) and behavioral noncompliance co-occurring with autism.

Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder

“…However, there was a significant increase in early morning awakenings, which reportedly decreased after 12 weeks of open-label treatment (Harfterkamp et al 2012(Harfterkamp et al , 2013. In spite of this, both the CHART study and the Harfterkamp RCT found that ATX was generally well tolerated Harfterkamp et al 2012;Tumuluru et al 2017) and acceptable to participant families (Hollway et al 2016).…”